$AMS Lot of eyes are on this low float gem! Top watch this week.
$AMS might be one of the most mispriced microcaps in the market right now.
• Cancer treatment infrastructure (REAL business)
• Long-term revenue backlog
• Expansion into new centers
• Tiny market cap